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The Genetic Absence Epilepsy Rats from Strasbourg (GAERS) are an inbreed Wistar rat
strain widely used as a model of genetic generalised epilepsy with absence seizures. As in
humans, the genetic architecture that results in genetic generalized epilepsy in GAERS is
poorly understood. Here we present the strain-specific variants found among the epileptic
GAERS and their related Non-Epileptic Control (NEC) strain. The GAERS and NEC repre-
sent a powerful opportunity to identify neurobiological factors that are associated with the
genetic generalised epilepsy phenotype.
Methods
We performed whole genome sequencing on adult epileptic GAERS and adult NEC rats, a
strain derived from the same original Wistar colony. We also generated whole genome
sequencing on four double-crossed (GAERS with NEC) F2 selected for high-seizing (n = 2)
and non-seizing (n = 2) phenotypes.
Results
Specific to the GAERS genome, we identified 1.12 million single nucleotide variants, 296.5K
short insertion-deletions, and 354 putative copy number variants that result in complete or
partial loss/duplication of 41 genes. Of the GAERS-specific variants that met high quality cri-
teria, 25 are annotated as stop codon gain/loss, 56 as putative essential splice sites, and 56
indels are predicted to result in a frameshift. Subsequent screening against the two F2 prog-
eny sequenced for having the highest and two F2 progeny for having the lowest seizure
burden identified only the selected Cacna1h GAERS-private protein-coding variant as
exclusively co-segregating with the two high-seizing F2 rats.
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Significance
This study highlights an approach for using whole genome sequencing to narrow down to a
manageable candidate list of genetic variants in a complex genetic epilepsy animal model,
and suggests utility of this sequencing design to investigate other spontaneously occurring
animal models of human disease.
Introduction
The genetic generalised epilepsies (GGE) comprise a group of epileptic disorders that include
absence seizures as one of the classical seizure phenotypes [1–3] with evidence that some cases
might be explained by a complex polygenic mode of inheritance [4–10]. Absence seizures are
characterized by diffuse cortical bilateral 3Hz spike-and-wave discharge (SWD) on electroen-
cephalogram (EEG) [1]. The Genetic Absence Epilepsy Rats from Strasbourg (GAERS) are a
well-validated rat model of spontaneous GGE with absence seizures that were selectively bred
from a Wistar colony that displayed spontaneous absence seizures [11, 12]. In parallel, a
counter strain was also bred from the same original colony, the Non-Epileptic Control (NEC)
rats, which were selectively bred for the lack of seizures and SWDs [12, 13]. Analogous to
human absence epilepsy, GAERS have spontaneously occurring SWDs that start and end
abruptly on a normal EEG background [5, 12, 13]. GAERS also exhibit a similar pharmacologi-
cal profile when compared to human absence seizures, being suppressed or aggravated by the
same anti-epileptic drugs [12–18]. Moreover, GAERS exhibit depressive-like behaviour and
elevated anxiety, analogous to the human behavioural profile of GGE [19–21]. Extensive cross
breeding studies have demonstrated that the GAERS epileptic phenotype is likely to be com-
plex and polygenic [12]. A genome-wide linkage scan of GAERS x Brown Norway (BN) F2 rats
reported three quantitative trait loci (QTL) in chromosomes 4, 7, and 8, associating with spe-
cific aspects of the SWD phenotype [22]. Despite three decades of study, only one GGE-associ-
ated genetic variant has been identified that has been implicated with the epilepsy phenotype.
We have published the missense (R1584P) variant in the low-threshold T-type calcium chan-
nel CaV3.2 gene (Cacna1h) as accounting for up to 33% of variance for the percentage of time
in seizures and the number of seizures based on data from F2 progeny of a cross between NEC
and GAERS rats [23, 24].
Taken together, the GAERS and NEC rats represent a powerful opportunity to identify
neurobiological factors associated with the GGE phenotype. Here, we performed whole
genome sequencing (WGS) on these two strains that have been selectively bred from the origi-
nal colony to characterise the genomic differences between them. We present the sequence
variation identified among the GAERS, NEC and their F2 progeny selected for high and non-
seizing phenotypes, using short-read next-generation sequence technology. We report a near
complete catalogue of strain-specific variants between the affected and unaffected strain, and
each compared to the reference BN genome.
Materials and methods
Ethics statement
All procedures on rats were approved by The University of Melbourne Animal Ethics commit-
tee (ethics numbers 1011823) and followed the Australian Code of Practice for the care and
use of animals for scientific purposes.
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EEG electrode implantation surgery
To identify the SWD phenotype, rats were anesthetised with isoflurane, then single midline
incision was made on the scalp posterior to the eyes to between the ears. Six holes were drilled
through the skull without penetrating the dura, one on each side anterior to the bregma, two
on each side posterior to the bregma and two to each side anterior to lambda. Recording
electrodes were screwed into each hole. Each recording electrode comprised a 1.3 mm gold
connector (Farnell Components, Chester Hill, Australia) soldered onto a nickel alloy jeweller
screw. The recording electrodes were fixed in position by applying Vertex dental cement
around the electrodes and over the skull. The incision was then sutured using nylon (4/0).
Immediately after surgery, each rat received an intraperitoneal injection of 1 ml/kg analgesic
solution containing intraperitoneal carprofen analgesic (5 mg/kg; Rimadyl; Pfizer Australia) in
0.9% sodium chloride. Post-surgical animals were assessed for neurological, weight and overall
appearance changes twice daily for the first 5 days following surgery, and then every other day
thereafter. Carprofen analgesia was given twice a day during the first 3 days after the surgery.
Animals are humanely euthanized if they present sustained signs of suffering during the course
of the experiments. All the animals used in our experiments had a satisfactory and prompt
recovery after the surgery.
Animals
We whole-genome sequenced female GAERS (n = 2), NEC (n = 2) and F2 GAERS x NEC
(n = 4) rats aged 16 weeks from our breeding colonies in Royal Melbourne Hospital. The rats
were originally obtained from the Strasbourg colony in 2007 (i.e. GAERS STRAS-MELB [24]).
The GAERS and NEC lines used for sequencing are at F82 and F74 filial generations, respec-
tively. All procedures were approved by the University of Melbourne Animal Ethics Commit-
tee (#1011823).
Breeding of the F2
The double cross matings used in this study were bred based on the CaV3.2 R1584P variant.
[23] First, GAERS homozygous for the R1584P variant were crossed with NEC rats that were
homozygous for the major allele to produce an F1 generation. Then, two F1 generation rats
were mated to produce an F2 generation. On average, 25% of the F2 progeny would be
expected to be homozygous for a given GAERS or NEC variant, 50% heterozygous for the
variant, and 25% to not carry the variant [23].
EEG recordings and spike and wave discharge analysis
Two weeks after surgery, the animals underwent two 24-hours periods of continuous EEG
recording with at least 2 days between each recording to confirm the epileptic phenotype. EEG
recordings were obtained using Profusion 3 software (Compumedics, Australia) unfiltered
and digitized at 512Hz.
EEG recordings were analysed for SWDs to give an electroencephalographic confirmation
of absence seizures. The analysis of the EEG was blinded using the SpikeWave Complex Finder
software (SWC, PLC van den Broek, Nijmegen University, Netherlands). The seizures detected
were confirmed manually using the following criteria: a SWD complex with an amplitude 3
times greater than the baseline, SWD frequency of 7–12 Hz and SWD duration longer than
0.5s, as previously described [24]. The seizures detected were confirmed manually using the
GAERS’ standard criteria for the classification of seizures, which includes; total number of sei-
zures, total time spent in seizure activity and average seizure duration were analysed. No
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seizures (or spike-wave discharges) were detected among our NEC rats (evaluated up until 12
months of age) or the no-seizing F2 rats.
Tissue collection
2–5 days after the last EEG recording session, animals were anesthetized using isoflurane at
5% (Ceva isofluorane, Piramal Enterprises Limited, India), then culled using a lethal dose of
intraperitoneal injection of lethabarb (150mg/kg IP; pentobarbitone sodium; Virbac, Aus.).
Liver and brain tissue where collected, snap frozen over liquid nitrogen and stored at -80˚C.
Extraction of genomic DNA
Genomic DNA (gDNA) was extracted from liver using the DNeasy Blood & Tissue Kit (QIA-
GEN) following the manufacturer’s protocol. Samples were incubated for 2 hours at 37˚C with
proteinase K (0.4μg) to digest the tissue and treated with 200μg of RNase to degrade any con-
taminating RNA. Once extracted, gDNA was stored at -80˚C.
Genome sequencing
We sequenced the GAERS and NEC genomes using paired-end sequencing libraries on an
Illumina HiSeq 2000 machine. We used the rat reference genome, version 3.4 (rattus norvegi-
cus), which represents>90% of the rat genome. Four female F2 animals were selected for
whole genome sequencing based on the number of seizures that they displayed. Two of the F2
animals had no seizures and did not carry the CaV3.2 R1584P variant (non-seizing F2). The
other two F2 animals selected were homozygous for CaV3.2 R1584P variant and displayed the
highest number of seizures per hour, 5.8 and 4.6 seizures respectively (high-seizing F2).
Concordance with genotyping chips
Rats from the GAERS and NEC strains have been independently genotyped in 2008 by the
STAR consortium using a single-nucleotide polymorphism (SNP) rat genotyping microarray
[25]. Of the 20,283 STAR consortium SNPs [25], 11,379 and 10,830 SNPs had been determined
to be polymorphic between the BN reference and the GAERS and NEC strains, respectively.
At QUAL PHRED consensus score30 and read depth3, the sequencing data from the
GAERS and NEC detected 11,292 and 10,648 of the 11,379 and 10,830 SNPs previously
assigned as polymorphic (99.24% and 98.32% sensitivity). Of the 8,475 and 8,624 positions
previously assigned as non-polymorphic, our sequencing data correctly assigned 8,408 and
8,440 as non-polymorphic (99.21% and 98.29% specificity). These results reflect high concor-
dance rates between the previous genotyping array and our own Illumina HiSeq sequencing
data. The minor discordances can be explained by differences in technologies and variant call-
ing platforms resulting in discordant variant calls at the false positive and false negative variant
sites. That the animals sequenced are being compared to genotype data from rats maintained
in a different laboratory for the last 20 generations would also result in minor discordance. For
the 67 (GAERS) and 184 (NEC) apparent false-positive SNPs, the sequencing consensus qual-
ity (QUAL) score was high (mean score 58.22 and 58.30) with close-to-average read depth
(average depth 13.70 and 15.44 reads). Interestingly, for 43 (64.2% GAERS) and 43 (23.4%
NEC) of the false positive (FP); and, 42 (48.28% GAERS) and 43 (23.63% NEC) of the apparent
false negatives (FN), the STAR BN/SsNHsd/Mcwi allele were also discordant with the BN ref-
erence genome, suggesting that this subset of apparent FP and FN SNPs may actually reflect
residual sequencing errors in the BN reference genome (RGSC-3.4).
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Results
Data access
The data sets supporting the results of this research article are included within the article; the
supporting additional files are presented as supplementary tables (S1–S6 Tables).
Sequencing
Whole genome sequencing of rat DNA was performed on the Illumina Hiseq 2000. To deter-
mine coverage, all gaps (stretches of N’s) in the rat reference genome (NCBI rattus norvegicus
RGSC v3.4 (b4); Ensembl core database release 67) were excluded, resulting in a reference of
2,718,881,021 bases. After accounting for PCR duplicates and reads that did not align to the
reference genome, in the GAERS, approximately 23.48 million reads (37.6 Gb) were mapped
to the BN reference genome (RGSC v3.4) using BWA [26] and variant calling using samtools
[27]. This resulted in 15.14-fold average coverage of the GAERS autosomal chromosomes, and
15.65-fold average coverage of the X-chromosome. Similarly, for the NEC rat, 26.48 million
reads (42.7 Gb) mapped to the BN reference genome, equating to 17.2-fold average coverage
of the NEC autosomal chromosomes, and 17.57-fold average coverage of the X-chromosome
(Table 1). In total, within the GAERS sequence, 98.2%, 96.9%, and 84.2% of non-gap, non-N
bases of the autosomal reference genome were covered by at least three, five or ten reads,
respectively. Similarly, for the NEC sequence, 98.4%, 97.5%, and 90.3% of non-gap, non-N
bases of the autosomal reference genome were covered by more than three, five, or ten reads,
respectively (Table 1).
The homozygous variant calls specific to each strain were: 1,119,180 and 1,051,188 single
nucleotide variants (representing 0.04% of bases covered with3-fold coverage and a quality
score30), in GAERS and NEC, respectively. There were 296,455 (GAERS) and 298,996
(NEC) strain-specific putative insertions-deletions (indels) (Table 2).


















Autosomal GAERS 15.14 99.1% 98.2% 96.9% 84.2% 48.3% 15.7%
NEC 17.20 99.1% 98.4% 97.5% 90.3% 63.9% 27.6%
X
chromosome
GAERS 15.65 99.1% 98.1% 96.7% 86.3% 54.8% 20.4%
NEC 17.57 99.2% 98.4% 97.4% 90.9% 68.0% 32.5%
https://doi.org/10.1371/journal.pone.0179924.t001
Table 2. Variant tallies compared to BN rat reference (RGSC v3.4 b4).
Strain
(n = 2 each)
Variant type Variants Homozygous Variants Strain-specific variants* (%)
GAERS SNV 3,910,940 3,713,694 1,119,180 (30.14%)
Indel# 1,000,916 954,008 296,455 (31.07%)
NEC SNV 3,863,956 3,663,472 1,051,188 (28.69%)
Indel# 1,022,912 967,666 298,996 (30.90%)
Contributing variants were required to have3-fold coverage and a PHRED QUAL (quality consensus) score30.
*Homozygous variants specific to corresponding strain, after excluding variants present in the other strain. Variants where the other strain had insufficient
(<3-fold) coverage or (QUAL<30) quality were omitted.
#Indels that overlapped a gap region in the rat reference genome were excluded.
https://doi.org/10.1371/journal.pone.0179924.t002
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Distribution of variants
Among the called single nucleotide variants (SNVs): 3,571 of 1,119,180 (0.32%) and 3,224 of
1,051,188 (0.31%) were GAERS and NEC specific non-synonymous variants with annotations
of missense, nonsense, or donor/acceptor splice variants. While 307 of 296,455 (0.10%) and
394 of 298,996 (0.13%) putative indels were GAERS and NEC specific variants with annota-
tions of missense, nonsense, donor/acceptor splice, complex indel or frameshift. Both SNVs
and indels were annotated using Ensembl variant effect predictor v2.5, based on Ensembl
release v67, rattus norvegicus. Distribution of the annotations from the GAERS and NEC spe-
cific variants are available in (Tables 3 and 4).
Strain-specific variants
To enrich for higher confidence protein-coding calls we took the 3,571 GAERS-specific and
3,224 NEC-specific non-synonymous SNVs and focused on those variants where the sequence
data of the corresponding strain achieved all of the following: a)10-fold coverage, b) a
QUAL score 30, c) a mapping quality (MQ) score 40, d) a genotype quality (GQ)
score 20 and e) 80% of total reads supported the variant allele (See S1 Table for GAERS
and S2 Table for NEC). We further screened these higher confidence GAERS (n = 2,270) and
NEC (n = 2,285) specific non-synonymous SNVs across other known rat variant databases:
STAR rat consortium, dbSNP, Ensembl, the SHR rat sequence, and two more recently pub-
lished consortia sequencing studies [28–32]. Herein, we refer to variants found in GAERS but
not NEC, and vice versa, as “specific” variants. Variants that are also absent among the avail-
able rat variation reference cohorts are referred to as GAERS or NEC “private” variants. When
screening out variants previously reported within external rat strains, the number of GAERS
Table 3. Annotations for single nucleotide variants observed only in one strain.
Annotation (SNVs) GAERS—Specific (%) NEC—Specific (%)
All variants 1,119,180 1,051,188
Stop gain 34 (0.0030%) 40 (0.0038%)
Stop loss 5 (0.00045%) 3 (0.00029%)
Splice donor/acceptor site 53 (0.0047%) 47 (0.0045%)
Missense 3,479 (0.31%) 3,134 (0.30%)
Coding unknown 12 (0.0011%) 16 (0.0015%)
Within noncoding gene 836 (0.075%) 848 (0.081%)
Mature miRNA 7 (0.00063%) 5 (0.00048%)
Synonymous 4,695 (0.42%) 4,300 (0.41%)
Splice region variant 604 (0.054%) 582 (0.055%)
5’ UTR 590 (0.053%) 464 (0.044%)
3’ UTR 2,855 (0.26%) 2,539 (0.24%)
Upstream 55,018 (4.92%) 57,203 (5.44%)
Downstream 54,056 (4.83%) 50,245 (4.78%)
Intronic 273,631 (24.45%) 252,563 (24.03%)
Intergenic 723,305 (64.63%) 679,199 (64.61%)
While a single variant can have multiple annotations due to overlapping transcripts, the variant annotations
are presented such that a single variant only contributes to a single annotation, based on the order of the
presented annotations.
https://doi.org/10.1371/journal.pone.0179924.t003
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and NEC private SNVs with non-synonymous annotations was 183 and 168 SNVs, respec-
tively (Table 5).
Of the strain specific high-confidence non-synonymous SNVs we found that 2,060
(90.75%) and 2,096 (91.73%) GAERS and NEC-specific SNVs successfully mapped from the
rat (Nov. 2004 [Baylor 3.4/rn4]) to the human (Feb. 2009 [GRCh37/hg19]) genome using Lift-
Over [33].
Of the 307 and 394 GAERS- and NEC-specific protein-coding indels variant calls, 110 and
154 passed the stringent quality control criteria as previously described for the SNV calls.
Of those, 78 GAERS- and 123 NEC-specific indels were located outside of repeat regions as
defined by the rattus norvegicus (rn4) repeatmasker, accessed from the University of Califor-
nia, Santa Cruz (UCSC) Genome Browser (https://genome.ucsc.edu/). (See S3 Table for
GAERS- and S4 Table for NEC-specific protein-coding indels).
Table 4. Annotations for indel variants observed in one strain and not the other, excluding indels overlapping non-reference sequence.
Annotation (Indels) GAERS—Specific (%) NEC―Specific (%)
All variants 296,455 298,996
Stop gain 1 (0.0003%) 0 (0.00%)
Splice donor/acceptor site 64 (0.022%) 74 (0.025%)
Frameshift 149 (0.05%) 204 (0.07%)
Codon Indels 121 (0.04%) 151 (0.05%)
Within noncoding gene 99 (0.033%) 127 (0.042%)
Mature miRNA 11 (0.0037%) 19 (0.0064%)
Splice region variant 202 (0.068%) 244 (0.082%)
5’ UTR 92 (0.030%) 85 (0.028%)
3’ UTR 836 (0.28%) 793 (0.27%)
Upstream 18,009 (6.07%) 18,240 (6.10%)
Downstream 14,896 (5.02%) 15,430 (5.16%)
Intronic 79,180 (26.71%) 80,114 (26.79%)
Intergenic 182,795 (61.66%) 183,515 (61.38%)
While a single variant can have multiple annotations due to overlapping transcripts, the variant annotations are presented such that a single variant only
contributes to a single annotation, based on the order of the presented annotations.
https://doi.org/10.1371/journal.pone.0179924.t004




High Confidence non-synonymous variants* 2,270 (100%) 2,285 (100%)
Successful in Liftover to GRCh37/hg19 2,060 (90.75%) 2,096 (91.73%)
Not observed in STAR SNP panel, dbSNP, Ensembl, or SHR rat
sequence
1,034 (45.55%) 1,128 (49.37%)
Absent among rat strains sequenced as part of Atanur et al (2013)
or Hermsen et al (2015).
183 (8.06%) 168 (7.35%)
* High confidence variants are defined by the sequence data of the corresponding strain achieving: a)
10-fold coverage, b) a QUAL score 30, c) a mapping quality (MQ) score 40, d) a genotype quality (GQ)
score 20 and e) 80% of reads supporting the variant allele (See S1 Table for GAERS and S2 Table for
NEC).
https://doi.org/10.1371/journal.pone.0179924.t005
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Copy number variants
We used the estimation by read depth with single-nucleotide variants (ERDS) platform, based
on read depth and paired-end mapping data [34] to identify copy number variants (CNVs)
among the GAERS and NEC sequence data. To qualify, CNV calls by ERDS were required to
be5000bps and to result in either complete loss of sequence (for deletions) or at least 2-fold
increase in instance (for duplications). As a result, 354 and 475 putative GAERS- and NEC-
specific CNVs were identified (S5 Table). Of the GAERS-specific putative CNVs, 39 (29 dupli-
cations and 10 deletions) are annotated to overlap with an exonic/splicing (coding) function.
Similarly, 30 NEC-specific putative CNVs (22 duplications and 8 deletions) overlap with
exonic/splicing coding sequence (S6 Table). CNVs of increasing size, as provided in field
“length” in S6 Table, are of increased confidence, however, all CNVs reported in S5 and S6
Tables represent putative CNV calls and no CNVs have been independently validated by addi-
tional sequencing technologies.
No GAERS or NEC CNV was found to overlap with a list of genes characterized by a “sei-
zure” associated phenotype among the Mouse Genome Informatics (MGI) and/or with the list
of candidate epilepsy genes as defined by Lemke and colleagues [35].
F2 variant screen
GAERS rats were crossed with NEC rats to produce an F1 generation. Heterozygous F1 genera-
tion rats were then mated to produce an F2 generation. To further identify variants with poten-
tially large effects, we compared the presence or absence of the 183 GAERS private variants
among four whole-genome sequenced F2 rats selected at the extremes of the GAERS and NEC
seizure phenotype spectrum (i.e. two high-seizing and two non-seizing F2 rats respectively),
and selected on the presence and absence of the previously reported Cacna1h variant. Of the
GAERS private variants, no additional non-synonymous variant beyond the Cacna1h variant
was homozygous among high-seizing F2 and absent among non-seizing F2 rats. We did not
find any candidate variants that could be associated with epilepsy when we screened the 168
private NEC variants in which the non-seizing F2 were homozygous and absent among the
high-seizing F2.
We then relaxed the requirement of carrier zygosity and co-occurrence with published rat
strains to permit identifying risk variants that may be present among other strains but not be
sufficient to cause the seizure phenotype alone. Of the 2,270 higher-confidence GAERS-spe-
cific SNVs, thirty-three variants were found exclusively among the two high-seizing F2 mice—
irrespective of zygosity (S1 Table). For this zygosity permissive screen we then required that
less than ~10% of the previously sequenced rat strains—none of which have reported to have a
GAERS epileptic and behavioural phenotype—shared the variant (http://rgd.mcw.edu/pub/
strain_specific_variants/). Thus, to qualify, the segregating GAERS-specific variant must also
be observed in less than four of the 28 rat genomes published by Atanur et al [31] and also in
less than five of the 40 strains recently published in Hermsen et al. [32]. Through this more
permissive screen we identified six rare GAERS-specific non-synonymous SNVs that were
transmitted to the two high-seizing but not the two non-seizing F2 animals, and were observed
in less than 10% of the other published rat strains. Aside from the pre-selected Cacna1h vari-
ant, no variant occurred in a gene of obvious biological relevance. Using similar criteria we
found fourteen NEC-specific non-synonymous SNVs transmitted to both non-seizing F2 but
not the two high-seizing F2 animals (Table 6). We found that 13 of these 14 NEC-specific non-
synonymous SNVs were located within a large block of 52.2Mbp on chromosome 7 from posi-
tions 69181224–121380101 (rn4 reference genome). The relevance of this stretch of sequence
to the non-epileptic phenotype is of interest for larger F2 sample sequencing studies.
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Discussion
The genetic architecture underlying some of the most common epilepsies remains unde-
scribed. This study used WGS to identify genetic variants in a validated spontaneous animal
model of GGE with absence seizures, the GAERS rat. Like the human condition, the GAERS
rat appears to have a complex genetic architecture with the F2 progeny of the GAERS and NEC
supporting polygenic determinants.
Estimates show that approximately 40% of the euchromatic rat genome is part of the euthe-
rian core (orthologous bases to both mice and humans) [36] with 97.5% of human ion channel
genes, the most heavily implicated set of genes in epilepsy, having a characterized rat ortholog
[37].
This sequencing study identified genetic variants that were found in the GAERS strain that
were absent in the rattus norvegicus reference genome (BN rat). This was independently
repeated for the NEC strain and here it would be able to detect epilepsy risk factors that might
be shared between the GAERS and the BN rat. We subsequently compared the GAERS and
NEC strain to find genetic variants that differed between the two inbred lines. Both strains
originated from the same outbred Wistar rat colony, which selectively bred based on the pres-
ence (GAERS) or absence (NEC) of spontaneously arisen absence seizures and the corre-
sponding SWD signatures.
We then screened strain-specific GAERS and NEC variants with variants found among F2
rats with either high- or non-seizing phenotypes [23]. To both identify candidate variants for
the seizure phenotype and to remove likely background rat genome variation, we focused on
the GAERS-specific and NEC-specific variants that were present in less than ~10% of the pre-
viously sequenced open-access rat strains [31, 32]. Subsequently, to better prioritize variants
with potential effects on the epilepsy phenotype we screened those candidate variants through
the whole genome sequence data generated on four F2 rats. We selected two F2 rats at each
Table 6.
Strain Gene Variant (rn4) Hg19 (Lift Over) Observed: Atanur 2013 (n = 28) Observed: Hermsen 2015 Tally (n = 40)
GAERS Enc1 chr2:27724615C>G ENC1 n = 2 n = 4
GAERS Tmem82 chr5:160516635G>A TMEM82 n = 1 n = 2
GAERS Rsl1d1 chr10:4315352C>T RSL1D1 n = 2 n = 2
GAERS Rsl1d1 chr10:4325924A>C SMOC1 n = 2 n = 2
GAERS D3ZL18_RAT chr10:5565552G>A APOO n = 3 n = 4
GAERS Cacna1h chr10:14629759C>G CACNA1H None None
NEC Ntrk3 1:133959580A>G NTRK3 None None
NEC F1M6H9_RAT 7:69181224A>G CTBS None None
NEC F1M6H9_RAT 7:69181798A>G SPATA1 None n = 1
NEC F1LXS3_RAT 7:69870734C>A MATN2 None n = 1
NEC LOC681820 7:69915154G>A C8orf47 None n = 1
NEC LOC681820 7:69915236C>T C8orf47 None None
NEC D3ZFH8_RAT 7:69922079T>G HMGB1P5 n = 3 n = 3
NEC D3ZFH8_RAT 7:69922335T>C HMGB1P5 None n = 1
NEC Pop1 7:69974814C>G POP1 None n = 1
NEC RGD1563045 7:75873231C>T SMOC1 None None
NEC E9PSK6_RAT 7:80373722A>G PKHD1L1 n = 1 n = 4
NEC D3ZPQ1_RAT 7:113438014A>T C8orf31 n = 2 n = 3
NEC Bik 7:121380074A>G BIK n = 3 n = 4
NEC Bik 7:121380101A>G BIK n = 3 n = 4
https://doi.org/10.1371/journal.pone.0179924.t006
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extreme (two high-seizing F2 and two non-seizing F2) of the GAERS and NEC seizure pheno-
type spectrum. Through this screen we identified six GAERS-specific variants that were trans-
mitted to the high-seizing but not the non-seizing F2 animals. Conversely, we identified
fourteen NEC-specific variants that were transmitted to the non-seizing but not the high-seiz-
ing F2 animals. Beyond the selected for Cacna1h missense variant [23] this approach did not
identify additional candidate variants of immediate interest to the phenotypes.
In the NEC filtering of the specific variants, three additional common variants (seen in over
five existing rat strain sequences–S2 Table) were found in genes that have been associated with
epilepsy and segregate with the two non-seizing F2 rats; Abat (4-aminobutyrate aminotransfer-
ase), Cyp11b3 (11-beta-hydroxylase) and Cyp11b2 (aldosterone synthase) [3, 12, 38–44]. While
we do not yet have data to support any relevance of these observations, the NEC-specific vari-
ants are of interest since it is known that many rat strains will develop spontaneous SWDs, par-
ticularly during mature adulthood, while inbred NEC do not record any SWDs or absence
seizures during the course of their life [13].
Spontaneously occurring animal models of complex human disease present a powerful
opportunity to better understand the genetic architecture and disease pathogenesis beyond
what is possible from monogenic animal models of disease. This work illustrates the applica-
tion of whole genome sequencing on an inbred spontaneously-occurring epilepsy rat strain
coupled with sequencing high- and non-seizing F2 rats to identify a subset of genetic variants
that might individually or collectively associate with the epilepsy phenotype. In this study we
cannot rule out contributions coming from common variants with small-modest effects on
absence epilepsy risk that are shared across many of the currently available rat strains. While
we were able to narrow down individual candidate variants based on F2 rat sequencing, this
study is not equipped to quantitatively assess the contribution of the GAERS and NEC variants
to their corresponding phenotypes. Future studies that generate sequence data across the full
spectrum of seizure phenotypes observed in the F2 rats is required to perform quantitative
assessments of possible oligogenic/polygenic interactions.
The approach used to narrow down candidates is applicable to other animal models that
have genetic predisposition to either genetic, like WAG/Rij, or acquired epilepsies. For
instance, this whole genome sequence approach can be applied to try to identify susceptibility
genes to the development of acquired epilepsy in the FAST (kindling-prone) and SLOW (kin-
dling-resistant) rat strains. Like the GAERS and NEC, the FAST and SLOW rats are a result of
selective breeding of genetic predisposition to develop focal seizures in the kindling model [45].
Conclusions
Overall, this study illustrates that the sequencing of naturally occurring inbred animal models
of human disease, when a related inbred control strain is available, can facilitate addressing
one of the long standing limitations encountered when investigating polygenic diseases in
human populations. Additional F2 sequencing along with extensive future studies of these
SNVs, indels, and structural variants in larger cohorts of carefully characterised GAERS and
NEC F2 rats could identify additional variants that may contribute to the risk of absence epi-
lepsy, and the contribution that each gene, individually and in combination, has to the vari-
ability of seizure characteristics that are observed in the F2 rats.
Supporting information
S1 Table. List of genes showing gain or loss of stop codon, or splice acceptor/donor site in
GAERS compared to BN reference genome.
(XLSX)
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S2 Table. List of genes showing missense codon specific to NEC compared to BN reference
genome (i.e., absent in GAERS).
(XLSX)
S3 Table. List of genes showing likely-gene-disrupting indels in GAERS genome as com-
pared to BN reference genome.
(XLSX)
S4 Table. List of genes showing likely-gene-disrupting indels in NEC genome as compared
to BN reference genome.
(XLSX)
S5 Table. Copy number variations (CNVs) between GAERS, NEC and BN genome pre-
dicted using ERDS.
(XLSX)
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